A Safety and Effectiveness Study of a New Multi-Purpose Contact Lens Care Solution

Exclusion Criteria

• •1. Females of childbearing potential (not surgically sterilized or postmenopausal) if any one of the following conditions are met:
• •* currently pregnant,
• •* plan to become pregnant during the study,
• •* are breast-feeding.
• •2. Wear of gas permeable contact lenses within the last 30 days.
• •3. Wear of polymethylmethacrylate lenses within the last 3 months.
• •4. No topical ocular prescription medications may be administered during the study period. Ongoing use of non-preserved artificial tears up to 4 times daily (with no changes in frequency or brand) is allowed. Ongoing use of the rewetting drop the subject customarily uses (with no switch in brand or type) is also permitted during the study period.
• •5. Current systemic disease affecting ocular health or use of topical or systemic medications that, in the Investigator's opinion, could affect ocular physiology or lens performance.
• •6. Ocular astigmatism of 2.00 D or greater in either eye based on the contact lens prescription.
• •7. Grade 2 or greater finding on any slit-lamp scale and/or corneal infiltrates of any grade during slit-lamp examination at Screening.
• •8. Any finding during slit-lamp examination that, in the Investigator's opinion, interferes with contact lens wear.
• •9. Scar or neovascularization within the central 4 millimeters (mm) of the cornea. Minor peripheral corneal scarring (that does not extend into the central zone) is permitted, if in the Investigator's judgment, it does not interfere with contact lens wear.
• •10. Aphakia.
• •11. Amblyopia.
• •12. History of any corneal surgery.
• •13. Allergy to any component of the study solutions.
• •14. Participation in any clinical study within the 2 weeks prior to entry into this study.